CORPORATE ACCESS

A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.

Your Search ImmuCell News

ImmuCell Receives $500,000 Loan from the Maine Technology

PORTLAND, Maine, June 16, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

PORTLAND, Maine, May 14, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (the "Company" or "ImmuCell"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell Announces Refinancing of its Bank Debt

PORTLAND, Maine, March 11, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell Announces Financial Results for Third Quarter of 2018

PORTLAND, Maine, Nov. 13, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell Hires Senior Director of Quality

PORTLAND, Maine, Aug. 07, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell Announces Sale of Certain Non-Core Assets

PORTLAND, Maine, July 25, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell to Join Russell Microcap Index

PORTLAND, Maine, June 25, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell Announces Financial Results for First Quarter of 2018

PORTLAND, Maine, May 14, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell Appoints Two New Members to its Board of Directors

PORTLAND, Maine, Jan. 30, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

read more

ImmuCell Announces Financial Results for Third Quarter of 2017

PORTLAND, Maine, Nov. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced unaudited...

read more

ImmuCell Announces Expansion of Sales and Marketing Team

PORTLAND, Maine, Sept. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries, today announced the...

read more
Skip to content